Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells

International Journal of Biological Macromolecules

Volumn 63, Issue , 2014, Pages 49-55

  Wang, Lei ^a   Zhang, Wen jun ^b   Xiu, Bing ^b   Ding, Yi ^b   Li, Ping ^b   Ye, Wei de ^a   Zhu, Qi ^a   Liang, Ai bin ^b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Chitosan nanoparticles; RNA interference; Vascular endothelial growth factor (VEGF)

Indexed keywords

CHITOSAN; CYTARABINE; LIPOFECTAMINE; NANOCOMPOSITE; NANOPARTICLE; SMALL INTERFERING RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; DOWN REGULATION; DRUG EFFICACY; FLT 1 GENE; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; VEGF GENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE;

CHITOSAN NANOPARTICLES; RNA INTERFERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84887599096     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2013.10.028     Document Type: Article

References (29)

1. Kalra M., Dinand V., Choudhary S., Sachdeva A., Yadav S.P. Indian Pediatr. 2013, 50:659-662.
2. Brander D., Rizzieri D., Gockerman J., Diehl L., Shea T.C., Decastro C., Moore J.O., Beaven A. Leuk. Lymphoma 2013.
3. Bolkun L., Lemancewicz D., Sobolewski K., Mantur M., Semeniuk J., Kulczynska A., Kloczko J., Dzieciol J. Adv. Med. Sci. 2012, 18-25.
4. Bellamy W.T., Richter L., Sirjani D., Roxas C., Glinsmann-Gibson B., Frutiger Y., Grogan T.M., List A.F. Blood 2001, 97:1427-1434.
5. Wang H., Keiser J.A. Circ. Res. 1998, 83:832-840.
6. Drevs J., Hofmann I., Hugenschmidt H., Wittig C., Madjar H., Muller M., Wood J., Martiny-Baron G., Unger C., Marme D. Cancer Res. 2000, 60:4819-4824.
7. Kaigler D., Krebsbach P.H., Polverini P.J., Mooney D.J. Tissue Eng. 2003, 9:95-103.
8. Gehrke I., Gandhirajan R.K., Poll-Wolbeck S.J., Hallek M., Kreuzer K.A. Mol. Med. 2011, 17:619-627.
9. Bellamy W.T., Richter L., Frutiger Y., Grogan T.M. Cancer Res. 1999, 59:728-733.
10. Aguayo A., Kantarjian H., Manshouri T., Gidel C., Estey E., Thomas D., Koller C., Estrov Z., O'Brien S., Keating M., Freireich E., Albitar M. Blood 2000, 96:2240-2245.
11. Padro T., Bieker R., Ruiz S., Steins M., Retzlaff S., Burger H., Buchner T., Kessler T., Herrera F., Kienast J., Muller-Tidow C., Serve H., Berdel W.E., Mesters R.M. Leukemia 2002, 16:1302-1310.
12. Glenjen N.I., Hatfield K., Bruserud O. Eur. J. Haematol. 2005, 74:24-34.
13. Pajusola K., Aprelikova O., Korhonen J., Kaipainen A., Pertovaara L., Alitalo R., Alitalo K. Cancer Res. 1992, 52:5738-5743.
14. Kharfan-Dabaja M.A., Patel S.A., Osunkoya A.O., Kojouri K., Kamble R., Yang J., Hashmi M., Ozer H., Selby G.B. Clin. Lab. Haematol. 2006, 28:254-258.
15. White H.B., Laux B.E., Dennis D. Science 1972, 175:1264-1266.
16. Doi N., Zenno S., Ueda R., Ohki-Hamazaki H., Ui-Tei K., Saigo K. Curr. Biol. 2003, 13:41-46.
17. Zhang L.Z., Cai X.S., Qian Z.K., Mei J., Ma X.H., Huang H.Y., Huang W.D. Zhonghua Zhong Liu Za Zhi 2007, 29:566-569.
18. Salva E., Kabasakal L., Eren F., Ozkan N., Cakalagaoglu F., Akbuga J. Nucleic Acid Ther. 2011, 22:40-48.
19. Gunther M., Lipka J., Malek A., Gutsch D., Kreyling W., Aigner A. Eur. J. Pharm. Biopharm. 2010, 77:438-449.
20. Hu L., Sun Y., Wu Y. Nanoscale 2013, 5:3103-3111.
21. Cheng M., Han J., Li Q., He B., Zha B., Wu J., Zhou R., Ye T., Wang W., Xu H., Hou Y. J. Biomed. Mater. Res. B: Appl. Biomater. 2012, 100:2035-2043.
22. Katas H., Alpar H.O. J. Control. Release 2006, 115:216-225.
23. Xu Q., Kambhampati S.P., Kannan R.M. Middle East Afr. J. Ophthalmol. 2013, 20:26-37.
24. Delcea M., Sternberg N., Yashchenok A.M., Georgieva R., Baumler H., Mohwald H., Skirtach A.G. ACS Nano 2012, 6:4169-4180.
25. Zhou H., Yang L., Li H., Gong H., Cheng L., Zheng H., Zhang L.M., Lan Y. Int. J. Nanomed. 2012, 7:4649-4660.
26. Mohammadi Z., Dorkoosh F.A., Hosseinkhani S., Amini T., Rahimi A.A., Najafabadi A.R., Tehrani M.R. Acta Pharm. 2012, 62:83-92.
27. Andersen M.O., Howard K.A., Paludan S.R., Besenbacher F., Kjems J. Biomaterials 2008, 29:506-512.
28. Paesler J., Gehrke I., Poll-Wolbeck S.J., Kreuzer K.A. Eur. J. Haematol. 2012, 89:373-384.
29. Valcarcel M., Mendoza L., Hernandez J.J., Carrascal T., Salado C., Crende O., Vidal-Vanaclocha F. J. Transl. Med. 2011, 9:142.